Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function

Raoul D Oude Engberink1, Susanne M A van der Pol, Ed A Döpp

  • 1Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. raoul@invivonmr.uu.nl

Radiology
|April 26, 2007
PubMed
Abstract

Insights

Superparamagnetic iron oxide (SPIO) effectively labels human monocytes for MRI detection without impacting cell function. Ultrasmall SPIO (USPIO) showed limited labeling efficiency in this study.

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Magnetic Resonance Imaging

Background:

  • Monocyte labeling with superparamagnetic iron oxide nanoparticles (SPIONs) is crucial for in vivo tracking using magnetic resonance imaging (MRI).
  • Comparing the efficacy of different SPION sizes, such as superparamagnetic iron oxide (SPIO) and ultrasmall SPIO (USPIO), is essential for optimizing labeling protocols.

Purpose of the Study:

  • To evaluate the efficiency of labeling human monocytes with SPIO compared to USPIO.
  • To assess the impact of iron incorporation on monocyte viability, migratory capacity, and proinflammatory cytokine production.

Main Methods:

  • Human monocytes were incubated with SPIO (150 nm) and USPIO (30 nm) at various iron concentrations (0.1–3.7 mg/mL).
  • Labeling efficiency was quantified using MRI relaxation time measurements and Prussian blue staining.
  • Cell viability, in vitro migration, and cytokine (IL-1, IL-6) production were assessed post-labeling.

Main Results:

  • SPIO labeling significantly increased R2 relaxation rates, indicating effective iron incorporation, while USPIO showed minimal effect at high concentrations.
  • Optimal SPIO labeling (1.0 mg Fe/mL) enhanced MRI detectability without compromising cell viability or migratory function.
  • No significant changes in IL-1 and IL-6 production were observed 24 hours after SPIO labeling.

Conclusions:

  • In vitro labeling of human monocytes with SPIO is highly effective and suitable for MRI detection.
  • SPIO labeling at 1.0 mg Fe/mL provides excellent contrast enhancement on MRI without adverse effects on cellular functions.
  • USPIOs demonstrated lower labeling efficiency compared to SPIOs under the tested conditions.

Related Concept Videos